The document discusses the impact of transparency on retail pharmaceutical prices, highlighting that price variation has existed since the 1960s and persists despite increased transparency. Factors such as price discrimination by retailers and insurers, along with high transaction costs for consumers, contribute significantly to price disparities. The document presents data on price comparisons among pharmacies, illustrating substantial differences in medication costs.